Chinese General Practice ›› 2022, Vol. 25 ›› Issue (10): 1220-1226.DOI: 10.12114/j.issn.1007-9572.2022.0141
Special Issue: 用药最新文章合辑; 高血压最新文章合辑
• Article • Previous Articles Next Articles
Improving Medication-taking Behavior and Blood Pressure in Hypertensive Patients Using the Stages of Change Model-based Health Education
1.Department of Social Medicine and Health Education,School of Public Health,Peking University,Beijing 100191,China
2.Shunyi Center for Disease Control and Prevention,Beijing 101399,China
*Corresponding author:HE Chao,Chief physician,Master supervisor;E-mail:sy_bgshc@163.com
Received:
2021-07-15
Revised:
2022-01-28
Published:
2022-04-05
Online:
2022-03-17
通讯作者:
何朝
基金资助:
CLC Number:
SUN Xinying, GUO Yi, CHEN Ping, HE Chao.
Improving Medication-taking Behavior and Blood Pressure in Hypertensive Patients Using the Stages of Change Model-based Health Education [J]. Chinese General Practice, 2022, 25(10): 1220-1226.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0141
项目 | 基线 | 3个月 | 6个月 | 12个月 | |||||
---|---|---|---|---|---|---|---|---|---|
对照组(n=194) | 干预组(n=206) | 对照组(n=173) | 干预组(n=202) | 对照组(n=143) | 干预组(n=147) | 对照组(n=129) | 干预组(n=134) | ||
性别 | |||||||||
男 | 51(26.3) | 68(33.0) | 42(24.3) | 67(33.2) | 31(21.7) | 43(29.3) | 42(32.6) | 38(28.4) | |
女 | 143(73.7) | 138(67.0) | 131(75.7) | 135(66.8) | 112(78.3) | 104(70.7) | 87(67.4) | 96(71.6) | |
χ2值 | 2.159 | 3.573 | 2.187 | 1.721 | |||||
P值 | 0.142 | 0.059 | 0.139 | 0.191 | |||||
年龄(岁) | |||||||||
<50 | 41(21.1) | 52(25.3) | 36(20.8) | 52(25.7) | 28(19.5) | 38(25.9) | 30(23.3) | 34(25.4) | |
50~ | 83(42.8) | 94(45.6) | 69(39.9) | 91(45.1) | 60(42.0) | 68(46.2) | 48(37.2) | 62(46.2) | |
≥60 | 70(36.1) | 60(29.1) | 68(39.3) | 59(29.2) | 55(38.5) | 41(27.9) | 51(39.5) | 38(28.4) | |
χ2值 | 2.396 | 4.355 | 4.002 | 11.667 | |||||
P值 | 0.302 | 0.113 | 0.135 | 0.003 | |||||
文化程度 | |||||||||
小学及以下 | 34(17.5) | 22(10.7) | 31(17.9) | 22(10.9) | 28(19.6) | 17(11.6) | 22(17.1) | 77(57.5) | |
初中 | 105(54.1) | 112(54.3) | 91(52.6) | 109(53.9) | 73(51.0) | 72(49.0) | 64(49.6) | 4(3.0) | |
高中/中专/技校 | 38(19.6) | 43 (20.9) | 34(19.7) | 42(20.8) | 26(18.2) | 34(23.1) | 27(20.9) | 30(22.4) | |
大专/大学 | 17(8.8) | 29(14.1) | 17(9.8) | 29(14.4) | 16(11.2) | 24(16.3) | 16(12.4) | 23(17.1) | |
χ2值 | 5.882 | 4.908 | 5.308 | 2.275 | |||||
P值 | 0.118 | 0.179 | 0.151 | 0.517 | |||||
婚姻状况 | |||||||||
有配偶 | 183(94.3) | 195(94.7) | 163(94.2) | 192(95.0) | 134(93.7) | 141(95.9) | 121(93.8) | 130(97.0) | |
无配偶 | 11(5.7) | 11(5.3) | 10(5.8) | 10(5.0) | 9(6.3) | 6(4.1) | 8(6.2) | 4(3.0) | |
χ2值 | 0.021 | 0.127 | 0.723 | 6.656 | |||||
P值 | 0.885 | 0.721 | 0.395 | 0.010 | |||||
家庭月收入(元) | |||||||||
<1 500 | 39(20.1) | 21(10.2) | 33(19.1) | 21(10.4) | 30(21.0) | 13(8.8) | 25(19.3) | 9(6.7) | |
1 500~ | 38(19.6) | 28(13.6) | 36(20.8) | 26(12.9) | 28(19.6) | 17(11.6) | 26(20.2) | 13(9.7) | |
3 000~ | 37(19.0) | 55(26.7) | 32(18.5) | 54(26.7) | 29(20.2) | 45(30.6) | 26(20.2) | 41(30.6) | |
5 000~ | 55(28.4) | 54(26.2) | 49(28.3) | 54(26.7) | 40(28.0) | 35(23.8) | 32(24.8) | 33(24.6) | |
10 000~ | 25(12.9) | 48(23.3) | 23(13.3) | 47(23.3) | 16(11.2) | 37(25.2) | 20(15.5) | 38(28.4) | |
χ2值 | 17.348 | 16.233 | 21.472 | 20.735 | |||||
P值 | 0.002 | 0.003 | <0.001 | <0.001 | |||||
高血压家族史 | |||||||||
有 | 129(66.5) | 141(68.4) | 117(67.6) | 139(68.8) | 95(66.4) | 101(68.7) | 87(67.4) | 92(68.7) | |
无 | 65(33.5) | 65(31.6) | 56(32.4) | 63(31.2) | 48(33.6) | 46(31.3) | 42(32.6) | 42(31.3) | |
χ2值 | 0.173 | 0.060 | 0.171 | 0.138 | |||||
P值 | 0.677 | 0.806 | 0.679 | 0.710 | |||||
医疗保险类型 | |||||||||
新型农村合作医疗保险 | 145(74.7) | 104(50.5) | 130(75.1) | 102(50.5) | 110(76.9) | 67(45.6) | 78(60.4) | 112(83.6) | |
城镇居民医疗保险和超转人员医疗保险a | 17(8.8) | 28(13.6) | 13(7.5) | 28(13.9) | 11(7.7) | 19(12.9) | 25(19.4) | 9(6.7) | |
城镇职工医疗保险或公费医疗 | 32(16.5) | 74(35.9) | 30(17.4) | 72(35.6) | 22(15.4) | 61(41.5) | 26(20.2) | 13(9.7) | |
χ2值 | 25.745 | 24.062 | 30.856 | 18.225 | |||||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | |||||
其他慢性病 | |||||||||
有 | 107(55.2) | 125(60.7) | 96(55.5) | 122(60.4) | 79(55.2) | 87(59.2) | 73(56.6) | 81(60.5) | |
无 | 87(44.8) | 81(39.3) | 77(44.5) | 80(39.6) | 64(44.8) | 60(40.8) | 56(43.4) | 53(39.5) | |
χ2值 | 1.252 | 0.921 | 0.459 | 0.403 | |||||
P值 | 0.263 | 0.337 | 0.498 | 0.525 |
Table 1 Comparison of the main characteristics of two groups of patients at different time points
项目 | 基线 | 3个月 | 6个月 | 12个月 | |||||
---|---|---|---|---|---|---|---|---|---|
对照组(n=194) | 干预组(n=206) | 对照组(n=173) | 干预组(n=202) | 对照组(n=143) | 干预组(n=147) | 对照组(n=129) | 干预组(n=134) | ||
性别 | |||||||||
男 | 51(26.3) | 68(33.0) | 42(24.3) | 67(33.2) | 31(21.7) | 43(29.3) | 42(32.6) | 38(28.4) | |
女 | 143(73.7) | 138(67.0) | 131(75.7) | 135(66.8) | 112(78.3) | 104(70.7) | 87(67.4) | 96(71.6) | |
χ2值 | 2.159 | 3.573 | 2.187 | 1.721 | |||||
P值 | 0.142 | 0.059 | 0.139 | 0.191 | |||||
年龄(岁) | |||||||||
<50 | 41(21.1) | 52(25.3) | 36(20.8) | 52(25.7) | 28(19.5) | 38(25.9) | 30(23.3) | 34(25.4) | |
50~ | 83(42.8) | 94(45.6) | 69(39.9) | 91(45.1) | 60(42.0) | 68(46.2) | 48(37.2) | 62(46.2) | |
≥60 | 70(36.1) | 60(29.1) | 68(39.3) | 59(29.2) | 55(38.5) | 41(27.9) | 51(39.5) | 38(28.4) | |
χ2值 | 2.396 | 4.355 | 4.002 | 11.667 | |||||
P值 | 0.302 | 0.113 | 0.135 | 0.003 | |||||
文化程度 | |||||||||
小学及以下 | 34(17.5) | 22(10.7) | 31(17.9) | 22(10.9) | 28(19.6) | 17(11.6) | 22(17.1) | 77(57.5) | |
初中 | 105(54.1) | 112(54.3) | 91(52.6) | 109(53.9) | 73(51.0) | 72(49.0) | 64(49.6) | 4(3.0) | |
高中/中专/技校 | 38(19.6) | 43 (20.9) | 34(19.7) | 42(20.8) | 26(18.2) | 34(23.1) | 27(20.9) | 30(22.4) | |
大专/大学 | 17(8.8) | 29(14.1) | 17(9.8) | 29(14.4) | 16(11.2) | 24(16.3) | 16(12.4) | 23(17.1) | |
χ2值 | 5.882 | 4.908 | 5.308 | 2.275 | |||||
P值 | 0.118 | 0.179 | 0.151 | 0.517 | |||||
婚姻状况 | |||||||||
有配偶 | 183(94.3) | 195(94.7) | 163(94.2) | 192(95.0) | 134(93.7) | 141(95.9) | 121(93.8) | 130(97.0) | |
无配偶 | 11(5.7) | 11(5.3) | 10(5.8) | 10(5.0) | 9(6.3) | 6(4.1) | 8(6.2) | 4(3.0) | |
χ2值 | 0.021 | 0.127 | 0.723 | 6.656 | |||||
P值 | 0.885 | 0.721 | 0.395 | 0.010 | |||||
家庭月收入(元) | |||||||||
<1 500 | 39(20.1) | 21(10.2) | 33(19.1) | 21(10.4) | 30(21.0) | 13(8.8) | 25(19.3) | 9(6.7) | |
1 500~ | 38(19.6) | 28(13.6) | 36(20.8) | 26(12.9) | 28(19.6) | 17(11.6) | 26(20.2) | 13(9.7) | |
3 000~ | 37(19.0) | 55(26.7) | 32(18.5) | 54(26.7) | 29(20.2) | 45(30.6) | 26(20.2) | 41(30.6) | |
5 000~ | 55(28.4) | 54(26.2) | 49(28.3) | 54(26.7) | 40(28.0) | 35(23.8) | 32(24.8) | 33(24.6) | |
10 000~ | 25(12.9) | 48(23.3) | 23(13.3) | 47(23.3) | 16(11.2) | 37(25.2) | 20(15.5) | 38(28.4) | |
χ2值 | 17.348 | 16.233 | 21.472 | 20.735 | |||||
P值 | 0.002 | 0.003 | <0.001 | <0.001 | |||||
高血压家族史 | |||||||||
有 | 129(66.5) | 141(68.4) | 117(67.6) | 139(68.8) | 95(66.4) | 101(68.7) | 87(67.4) | 92(68.7) | |
无 | 65(33.5) | 65(31.6) | 56(32.4) | 63(31.2) | 48(33.6) | 46(31.3) | 42(32.6) | 42(31.3) | |
χ2值 | 0.173 | 0.060 | 0.171 | 0.138 | |||||
P值 | 0.677 | 0.806 | 0.679 | 0.710 | |||||
医疗保险类型 | |||||||||
新型农村合作医疗保险 | 145(74.7) | 104(50.5) | 130(75.1) | 102(50.5) | 110(76.9) | 67(45.6) | 78(60.4) | 112(83.6) | |
城镇居民医疗保险和超转人员医疗保险a | 17(8.8) | 28(13.6) | 13(7.5) | 28(13.9) | 11(7.7) | 19(12.9) | 25(19.4) | 9(6.7) | |
城镇职工医疗保险或公费医疗 | 32(16.5) | 74(35.9) | 30(17.4) | 72(35.6) | 22(15.4) | 61(41.5) | 26(20.2) | 13(9.7) | |
χ2值 | 25.745 | 24.062 | 30.856 | 18.225 | |||||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | |||||
其他慢性病 | |||||||||
有 | 107(55.2) | 125(60.7) | 96(55.5) | 122(60.4) | 79(55.2) | 87(59.2) | 73(56.6) | 81(60.5) | |
无 | 87(44.8) | 81(39.3) | 77(44.5) | 80(39.6) | 64(44.8) | 60(40.8) | 56(43.4) | 53(39.5) | |
χ2值 | 1.252 | 0.921 | 0.459 | 0.403 | |||||
P值 | 0.263 | 0.337 | 0.498 | 0.525 |
服药行为阶段 | 基线 | 3个月 | 6个月 | 12个月 | ||||
---|---|---|---|---|---|---|---|---|
对照组(n=194) | 干预组(n=206) | 对照组(n=173) | 干预组(n=202) | 对照组(n=143) | 干预组(n=147) | 对照组(n=126) | 干预组(n=134) | |
意向前期 | 53(27.3) | 83(40.3) | 70(40.5) | 61(30.2) | 57(39.9) | 48(32.7) | 51(40.5) | 37(27.6) |
意向准备期 | 44(22.7) | 66(32.0) | 32(18.5) | 32(15.8) | 26(18.2) | 20(13.6) | 26(20.6) | 16(11.9) |
行动期 | 97(50.0) | 57(27.7) | 34(19.6) | 38(18.8) | 16(11.2) | 13(8.8) | 6(4.8) | 10(7.5) |
维持期 | 0 | 0 | 37(21.4) | 71(35.2) | 44(30.7) | 66(44.9) | 43(34.1) | 71(53.0) |
χ2值 | 21.066 | 6.436 | 4.097 | 12.251 | ||||
P值 | <0.001 | 0.040 | 0.129 | 0.002 |
Table 2 Comparison of medication-taking behavior between two groups of hypertensive patients at different time points
服药行为阶段 | 基线 | 3个月 | 6个月 | 12个月 | ||||
---|---|---|---|---|---|---|---|---|
对照组(n=194) | 干预组(n=206) | 对照组(n=173) | 干预组(n=202) | 对照组(n=143) | 干预组(n=147) | 对照组(n=126) | 干预组(n=134) | |
意向前期 | 53(27.3) | 83(40.3) | 70(40.5) | 61(30.2) | 57(39.9) | 48(32.7) | 51(40.5) | 37(27.6) |
意向准备期 | 44(22.7) | 66(32.0) | 32(18.5) | 32(15.8) | 26(18.2) | 20(13.6) | 26(20.6) | 16(11.9) |
行动期 | 97(50.0) | 57(27.7) | 34(19.6) | 38(18.8) | 16(11.2) | 13(8.8) | 6(4.8) | 10(7.5) |
维持期 | 0 | 0 | 37(21.4) | 71(35.2) | 44(30.7) | 66(44.9) | 43(34.1) | 71(53.0) |
χ2值 | 21.066 | 6.436 | 4.097 | 12.251 | ||||
P值 | <0.001 | 0.040 | 0.129 | 0.002 |
变量 | 赋值 |
---|---|
服药行为阶段 | 意向前期=1,意向准备期=2,行动维持期=3 |
组别 | 对照组=0,干预组=1 |
随访时间点 | 基线=0,3个月=1,6个月=2,12个月=3 |
性别 | 男=0,女=1 |
年龄(岁) | <50=0,50~=1,≥60=2 |
文化程度 | 小学及以下=1,初中=2,高中/中专/技校=3,大专/大学=4 |
婚姻状况 | 无配偶=0,有配偶=1 |
家庭月收入(元) | <1 500=0,1 500~=1,3 000~=2,5 000~=3,10 000~=4 |
医疗保险类型 | 新型农村合作医疗保险=0,城镇居民医疗保险和超转人员医疗保险=1,城镇职工医疗保险和公费=2 |
其他常见慢性病 | 有=0,无=1 |
高血压家族史 | 有=0,无=1 |
服药障碍得分 | 以实际值纳入 |
Table 3 Variable assignment table
变量 | 赋值 |
---|---|
服药行为阶段 | 意向前期=1,意向准备期=2,行动维持期=3 |
组别 | 对照组=0,干预组=1 |
随访时间点 | 基线=0,3个月=1,6个月=2,12个月=3 |
性别 | 男=0,女=1 |
年龄(岁) | <50=0,50~=1,≥60=2 |
文化程度 | 小学及以下=1,初中=2,高中/中专/技校=3,大专/大学=4 |
婚姻状况 | 无配偶=0,有配偶=1 |
家庭月收入(元) | <1 500=0,1 500~=1,3 000~=2,5 000~=3,10 000~=4 |
医疗保险类型 | 新型农村合作医疗保险=0,城镇居民医疗保险和超转人员医疗保险=1,城镇职工医疗保险和公费=2 |
其他常见慢性病 | 有=0,无=1 |
高血压家族史 | 有=0,无=1 |
服药障碍得分 | 以实际值纳入 |
变量 | b | SE | Wald χ2值 | df | P值 | OR(95%CI) | |
---|---|---|---|---|---|---|---|
截距 | |||||||
服药行为阶段=1 | -0.079 | 0.393 | 0.041 | 1 | 0.840 | 0.924(0.428,1.995) | |
服药行为阶段=2 | 0.814 | 0.394 | 4.272 | 1 | 0.039 | 2.258(1.043,4.888) | |
年龄(岁) | |||||||
50~ | 0.301 | 0.244 | 1.524 | 1 | 0.217 | 1.351(0.838,2.178) | |
≥60 | 0.831 | 0.263 | 9.970 | 1 | 0.002 | 2.296(1.371,3.846) | |
医疗保险类型 | |||||||
城镇居民医疗保险和超转人员医疗保险 | 0.417 | 0.280 | 2.217 | 1 | 0.137 | 1.517(0.877,2.625) | |
城镇职工医疗保险和公费医疗 | 0.077 | 0.239 | 0.104 | 1 | 0.747 | 1.080(0.676,1.726) | |
服药障碍得分 | 0.037 | 0.016 | 5.263 | 1 | 0.018 | 1.038(1.006,1.070) | |
组别 | |||||||
干预组 | -0.755 | 0.195 | 14.967 | 1 | <0.001 | 0.470(0.320,0.689) | |
随访时间点 | |||||||
3个月 | -0.526 | 0.137 | 14.653 | 1 | <0.001 | 0.591(0.452,0.774) | |
6个月 | -0.506 | 0.157 | 10.422 | 1 | 0.001 | 0.603(0.443,0.820) | |
12个月 | -0.496 | 0.224 | 4.887 | 1 | 0.027 | 0.609(0.392,0.945) | |
组别×随访时间点a | |||||||
干预组×3个月 | 1.368 | 0.205 | 44.551 | 1 | <0.001 | 3.928(2.628,5.870) | |
干预组×6个月 | 1.295 | 0.228 | 32.149 | 1 | <0.001 | 3.651(2.333,5.712) | |
干预组×12个月 | 1.419 | 0.296 | 23.041 | 1 | <0.001 | 4.133(2.315,7.377) |
Table 4 Generalized estimation equation model of medication behavior stage of two groups of hypertensive patients
变量 | b | SE | Wald χ2值 | df | P值 | OR(95%CI) | |
---|---|---|---|---|---|---|---|
截距 | |||||||
服药行为阶段=1 | -0.079 | 0.393 | 0.041 | 1 | 0.840 | 0.924(0.428,1.995) | |
服药行为阶段=2 | 0.814 | 0.394 | 4.272 | 1 | 0.039 | 2.258(1.043,4.888) | |
年龄(岁) | |||||||
50~ | 0.301 | 0.244 | 1.524 | 1 | 0.217 | 1.351(0.838,2.178) | |
≥60 | 0.831 | 0.263 | 9.970 | 1 | 0.002 | 2.296(1.371,3.846) | |
医疗保险类型 | |||||||
城镇居民医疗保险和超转人员医疗保险 | 0.417 | 0.280 | 2.217 | 1 | 0.137 | 1.517(0.877,2.625) | |
城镇职工医疗保险和公费医疗 | 0.077 | 0.239 | 0.104 | 1 | 0.747 | 1.080(0.676,1.726) | |
服药障碍得分 | 0.037 | 0.016 | 5.263 | 1 | 0.018 | 1.038(1.006,1.070) | |
组别 | |||||||
干预组 | -0.755 | 0.195 | 14.967 | 1 | <0.001 | 0.470(0.320,0.689) | |
随访时间点 | |||||||
3个月 | -0.526 | 0.137 | 14.653 | 1 | <0.001 | 0.591(0.452,0.774) | |
6个月 | -0.506 | 0.157 | 10.422 | 1 | 0.001 | 0.603(0.443,0.820) | |
12个月 | -0.496 | 0.224 | 4.887 | 1 | 0.027 | 0.609(0.392,0.945) | |
组别×随访时间点a | |||||||
干预组×3个月 | 1.368 | 0.205 | 44.551 | 1 | <0.001 | 3.928(2.628,5.870) | |
干预组×6个月 | 1.295 | 0.228 | 32.149 | 1 | <0.001 | 3.651(2.333,5.712) | |
干预组×12个月 | 1.419 | 0.296 | 23.041 | 1 | <0.001 | 4.133(2.315,7.377) |
组别 | 基线 | 3个月 | 6个月 | 12个月 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
例数 | 收缩压 | 舒张压 | 例数 | 收缩压 | 舒张压 | 例数 | 收缩压 | 舒张压 | 例数 | 收缩压 | 舒张压 | ||
对照组 | |||||||||||||
男 | 51 | 139±16 | 87±11 | 42 | 137±11 | 88±8 | 31 | 137±14 | 85±10 | 42 | 140±15 | 88±9 | |
女 | 143 | 136±12 | 84±10 | 131 | 136±14 | 85±8 | 112 | 132±14 | 80±11 | 87 | 136±15 | 82±9 | |
干预组 | |||||||||||||
男 | 68 | 144±16 | 86±13 | 67 | 136±12 | 83±9 | 43 | 136±12 | 81±9 | 38 | 137±16 | 82±11 | |
女 | 138 | 140±13 | 83±11 | 135 | 135±14 | 81±9 | 104 | 130±16 | 77±10 | 96 | 132±14 | 77±8 |
Table 5 Comparison of blood pressure between two groups of hypertensive patients at different time points
组别 | 基线 | 3个月 | 6个月 | 12个月 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
例数 | 收缩压 | 舒张压 | 例数 | 收缩压 | 舒张压 | 例数 | 收缩压 | 舒张压 | 例数 | 收缩压 | 舒张压 | ||
对照组 | |||||||||||||
男 | 51 | 139±16 | 87±11 | 42 | 137±11 | 88±8 | 31 | 137±14 | 85±10 | 42 | 140±15 | 88±9 | |
女 | 143 | 136±12 | 84±10 | 131 | 136±14 | 85±8 | 112 | 132±14 | 80±11 | 87 | 136±15 | 82±9 | |
干预组 | |||||||||||||
男 | 68 | 144±16 | 86±13 | 67 | 136±12 | 83±9 | 43 | 136±12 | 81±9 | 38 | 137±16 | 82±11 | |
女 | 138 | 140±13 | 83±11 | 135 | 135±14 | 81±9 | 104 | 130±16 | 77±10 | 96 | 132±14 | 77±8 |
变量 | 收缩压 | 舒张压 | |||||
---|---|---|---|---|---|---|---|
b(95%CI) | SE | P值 | b(95%CI) | SE | P值 | ||
截距 | 140.882(136.274,145.489) | 2.351 | <0.001 | 86.602(83.421,89.784) | 1.623 | <0.001 | |
性别 | |||||||
男 | 3.710(1.946,5.474) | 0.900 | <0.001 | 3.744(2.526,4.962) | 0.621 | <0.001 | |
年龄(岁) | |||||||
50~ | - | - | - | -1.526(-3.223,0.171) | 0.866 | 0.078 | |
≥60 | - | - | - | -4.187(-6.049,-2.325) | 0.950 | <0.001 | |
文化程度 | |||||||
初中 | -3.335(-5.735,-0.935) | 1.224 | 0.006 | - | - | - | |
高中/中专/技校 | -4.593(-7.475,-1.711) | 1.471 | 0.002 | - | - | - | |
大专/大学 | -4.618(-8.527,-0.709) | 1.994 | 0.021 | - | - | - | |
家庭月收入(元) | |||||||
1 500~ | -6.453(-9.412,-3.493) | 1.510 | <0.001 | -2.873(-4.917,-0.830) | 1.043 | 0.006 | |
3 000~ | -2.199(-4.999,0.602) | 1.429 | 0.124 | -0.266(-2.200,1.668) | 0.987 | 0.788 | |
5 000~ | -4.983(-7.742,-2.224) | 1.408 | <0.001 | -1.529(-3.434,0.376) | 0.972 | 0.116 | |
10 000~ | -3.200(-6.190,-0.210) | 1.525 | 0.036 | 0.160(-1.905,2.224) | 1.053 | 0.879 | |
高血压家族史 | |||||||
无 | - | - | - | 1.358(0.175,2.541) | 0.603 | 0.024 | |
服药行为阶段 | |||||||
意向准备期 | 1.602(-0.562,3.765) | 1.104 | 0.147 | 1.575(0.081,3.069) | 0.762 | 0.039 | |
行动维持期 | -2.295(-4.092,-0.497) | 0.917 | 0.012 | -2.010(-3.251,-0.768) | 0.633 | 0.002 | |
组别 | |||||||
干预组 | 3.572(0.805,6.339) | 1.412 | 0.011 | -1.926(-3.837,-0.015) | 0.975 | 0.048 | |
随访时点 | |||||||
3个月 | -0.539(-3.369,2.291) | 1.444 | 0.709 | 1.267(-0.688,3.221) | 0.997 | 0.204 | |
6个月 | -4.069(-7.076,-1.062) | 1.534 | 0.008 | -4.289(-6.366,-2.213) | 1.060 | <0.001 | |
12个月 | -0.093(-3.569,3.382) | 1.773 | 0.958 | -2.358(-4.757,0.042) | 1.224 | 0.054 | |
组别×随访时间点a | |||||||
干预组×3个月 | -4.616(-8.558,-0.675) | 2.011 | 0.022 | -3.549(-6.271,-0.827) | 1.389 | 0.011 | |
干预组×6个月 | -4.348(-8.569,-0.127) | 2.154 | 0.044 | -0.689(-3.604,2.226) | 1.487 | 0.643 | |
干预组×12个月 | -6.462(-11.208,-1.716) | 2.422 | 0.008 | -2.787(-6.064,0.491) | 1.672 | 0.096 |
Table 6 Generalized estimation equation model of factors associated with systolic and diastolic blood pressure levels in two groups of hypertensive patients
变量 | 收缩压 | 舒张压 | |||||
---|---|---|---|---|---|---|---|
b(95%CI) | SE | P值 | b(95%CI) | SE | P值 | ||
截距 | 140.882(136.274,145.489) | 2.351 | <0.001 | 86.602(83.421,89.784) | 1.623 | <0.001 | |
性别 | |||||||
男 | 3.710(1.946,5.474) | 0.900 | <0.001 | 3.744(2.526,4.962) | 0.621 | <0.001 | |
年龄(岁) | |||||||
50~ | - | - | - | -1.526(-3.223,0.171) | 0.866 | 0.078 | |
≥60 | - | - | - | -4.187(-6.049,-2.325) | 0.950 | <0.001 | |
文化程度 | |||||||
初中 | -3.335(-5.735,-0.935) | 1.224 | 0.006 | - | - | - | |
高中/中专/技校 | -4.593(-7.475,-1.711) | 1.471 | 0.002 | - | - | - | |
大专/大学 | -4.618(-8.527,-0.709) | 1.994 | 0.021 | - | - | - | |
家庭月收入(元) | |||||||
1 500~ | -6.453(-9.412,-3.493) | 1.510 | <0.001 | -2.873(-4.917,-0.830) | 1.043 | 0.006 | |
3 000~ | -2.199(-4.999,0.602) | 1.429 | 0.124 | -0.266(-2.200,1.668) | 0.987 | 0.788 | |
5 000~ | -4.983(-7.742,-2.224) | 1.408 | <0.001 | -1.529(-3.434,0.376) | 0.972 | 0.116 | |
10 000~ | -3.200(-6.190,-0.210) | 1.525 | 0.036 | 0.160(-1.905,2.224) | 1.053 | 0.879 | |
高血压家族史 | |||||||
无 | - | - | - | 1.358(0.175,2.541) | 0.603 | 0.024 | |
服药行为阶段 | |||||||
意向准备期 | 1.602(-0.562,3.765) | 1.104 | 0.147 | 1.575(0.081,3.069) | 0.762 | 0.039 | |
行动维持期 | -2.295(-4.092,-0.497) | 0.917 | 0.012 | -2.010(-3.251,-0.768) | 0.633 | 0.002 | |
组别 | |||||||
干预组 | 3.572(0.805,6.339) | 1.412 | 0.011 | -1.926(-3.837,-0.015) | 0.975 | 0.048 | |
随访时点 | |||||||
3个月 | -0.539(-3.369,2.291) | 1.444 | 0.709 | 1.267(-0.688,3.221) | 0.997 | 0.204 | |
6个月 | -4.069(-7.076,-1.062) | 1.534 | 0.008 | -4.289(-6.366,-2.213) | 1.060 | <0.001 | |
12个月 | -0.093(-3.569,3.382) | 1.773 | 0.958 | -2.358(-4.757,0.042) | 1.224 | 0.054 | |
组别×随访时间点a | |||||||
干预组×3个月 | -4.616(-8.558,-0.675) | 2.011 | 0.022 | -3.549(-6.271,-0.827) | 1.389 | 0.011 | |
干预组×6个月 | -4.348(-8.569,-0.127) | 2.154 | 0.044 | -0.689(-3.604,2.226) | 1.487 | 0.643 | |
干预组×12个月 | -6.462(-11.208,-1.716) | 2.422 | 0.008 | -2.787(-6.064,0.491) | 1.672 | 0.096 |
[1] | 国家卫健委:中国居民营养与慢性病状况报告(2020年)[EB/OL]. [2021-06-10]. . |
[2] | LU J P,LU Y,WANG X C,et al. Prevalence,awareness,treatment,and control of hypertension in China:data from 1.7 million adults in apopulation-based screening study(China PEACE Million Persons Project)[J]. Lancet,2017,390(10112):2549-2558. |
[3] | PROCHASKA J O,NORCROSS J C. Systems of psychotherapy:a transtheoretical analysis[J]. J Comput Theor Nanos,1979,12(9):2732-2739. |
[4] | PROCHASKA J O,DICLEMENTE C C,NORCROSS J C. In search of how people change:applications to addictive behaviors[J]. Am Psychol,1992,47(9):1102-1114. |
[5] | 孙昕霙. 健康调查问卷设计原理与实践[M]. 北京:北京大学医学出版社,2020. |
[6] | 邹益群. 社区高血压患者服药依从性行为阶段的调查及干预研究[D]. 福州:福建医科大学,2012. |
[7] | 陈怡静. 基于跨理论模型的入户访视对老年高血压患者服药行为的影响[D]. 郑州:郑州大学,2020. |
[8] | 刘甜,刘杏,李胜玲,等. 基于跨理论模型的社区家庭访视护理对老年高血压患者服药遵从行为的影响[J]. 中华护理杂志,2016,51(5):629-634. DOI:10.3761/j.issn.0254-1796.2016.05.025. |
[9] | JOHNSON S S,DRISKELL M M,JOHNSON J L,et al. Efficacy of a transtheoretical model-based expert system for antihypertensive adherence[J]. Dis Manag,2006,9(5):291-301. |
[10] | 曹雪群. 动机性访谈及跨理论模型干预对老年高血压患者自我管理的影响[D]. 广州:南方医科大学,2012 |
[11] | SCALA D,D'AVINO M,COZZOLINO S,et al. Promotion of behavioural change in people with hypertension:an intervention study[J]. Pharm World Sci,2008,30(6):834-839. |
[12] | JOHNSON S S,DRISKELL M M,JOHNSON J L,et al. Transtheoretical model intervention for adherence to lipid-lowering drugs[J]. Dis Manag,2006,9(2):102-114. |
[13] | IMERI H,TOTH J,ARNOLD A,et al. Use of the transtheoretical model in medication adherence:a systematic review[J]. Res Social Adm Pharm,2022. [Epub ahead of print]. DOI:10.1016/J.SAPHARM.2021.07.008. |
[1] | WU Wenjun, WEI Jingjing, LI Xue, REN Hongjie, YU Rui, PENG Guangcao, ZHU Mingjun. Regularity of Prescriptions for Coronary Heart Disease with Hypertension Based on Latent Structure and Association Rules [J]. Chinese General Practice, 2025, 28(30): 3787-3795. |
[2] | BAI Jiaxin, CHEN Yu, ZHOU Yiheng, LIU Lidi, YANG Rong, YAO Yi, YUAN Bo, ZHANG Yonggang, LEI Yi, ZENG Rui, JIA Yu, LIAO Xiaoyang. Assessment and Treatment of Early-onset Hypertension: Position Statement of the British and Irish Hypertension Association and Its Implications for Clinical Management of Early-onset Hypertension in China [J]. Chinese General Practice, 2025, 28(30): 3741-3746. |
[3] | QIN Bangguo, SUN Jin, LI Man, QIU Jiaojiao, CHENG Bokai, ZHU Ping, WANG Shuxia. Relationship between Non-high-density Lipoprotein Cholesterol to High-density Lipoprotein Cholesterol Ratio and Left Ventricular Hypertrophy in a Community-based Hypertensive Population [J]. Chinese General Practice, 2025, 28(30): 3753-3760. |
[4] | HAN Xiao, LI Qiyu, GE Pu, FAN Siyuan, LIU Diyue, WU Yibo, ZHANG Qingshuang. The Impact of Behavioral Lifestyle on Quality of Life in Hypertensive Patients [J]. Chinese General Practice, 2025, 28(26): 3248-3258. |
[5] | YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le. Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural [J]. Chinese General Practice, 2025, 28(25): 3137-3143. |
[6] | TANG Shangfeng, HUANG Yangzhen, PAN Yangyang, ZHENG Yanxi, XIONG Zhongbao, ZHANG Kangkang, SONG Jia, WEI Yilin, WANG Chunying, DONG Heng, CHEN Manwei, QING Hua. Specification for the Integration of Healthcare and Prevention Services in Hypertension at the Primary Level [J]. Chinese General Practice, 2025, 28(25): 3089-3095. |
[7] | WEI Yunhong, YANG Li, WANG Yulu, YE Qiufang, DAI Anni, HE Yan. Study on Cardiopulmonary Function During Different Exercise Stages in Patients with Obesity-related Hypertension [J]. Chinese General Practice, 2025, 28(24): 2972-2978. |
[8] | HE Jinyu, ZHULIDUZI Jiesisibieke, ZHANG Ning, LIU Min, LIANG Wannian. Research on Blood Pressure Control and Its Determinants Among Hypertensive Patients Under Standardized Management in China: Status, Challenges, and Future Directions [J]. Chinese General Practice, 2025, 28(24): 2968-2971. |
[9] | CHEN Youlan, LAN Yanqi, WU Ahua, ZHANG Haixia, HUANG Jiankang, GUO Zhinan. The Health Management Effect of Contracted Family Doctor Services under the Joint Management of Three Teachers in Xiamen City on Elderly Hypertensive Patients [J]. Chinese General Practice, 2025, 28(22): 2769-2775. |
[10] | HAO Aihua, ZENG Ziying, JIN Aiqiong, TANG Lingling, ZHENG Zique, MA Jingtai, ZHAO Jianguo, ZENG Weilin, XIAO Jianpeng, NIE Hui, YANG Ying. Analysis of Factors Influencing Avoidable Hospitalization for Elderly Hypertensive Patients [J]. Chinese General Practice, 2025, 28(19): 2370-2375. |
[11] | WANG Zhijun, ZHANG Shibo, LIU Jie, LI Dongqi, ZHENG Meijia, ZHOU Jianzhi. Correlation Analysis between TyG-BMI Index and Nocturnal Hypertension in Patients with Hypertension [J]. Chinese General Practice, 2025, 28(18): 2212-2221. |
[12] | ZHANG Zhidong, JIN Hua, HU Jihong, JIANG Lu, WANG Li, LONG Kaichong, ZHANG Ronghua. Analysis and Prediction of the Incidence and Mortality Trends of Hypertensive Nephropathy in China from 1990 to 2021 [J]. Chinese General Practice, 2025, 28(18): 2262-2269. |
[13] | HE Yan, CUI Saixian, HU Yang, NI Qing, GAN Lulu, LIU Qian, DAI Anni, LIU Shijie, YANG Li. Influencing Factors on Urinary Sodium Excretion in Patients with Obstructive Sleep Apnea-Associated Hypertension [J]. Chinese General Practice, 2025, 28(18): 2222-2227. |
[14] | LYU Lulu, ZHU Wanjie, XIAO Mingyang, LI Yike, ZHANG Juan. Correlation Analysis of the Circadian Rhythmicity of Blood Pressure with Ox-LDL/β2GPI Complex and Carotid Atherosclerosis in Patients with Essential Hypertension [J]. Chinese General Practice, 2025, 28(18): 2228-2233. |
[15] | MEI Jingyan, CHEN Min, ZHANG Lieqiang, PAN Yunxi, WANG Xin, ZHAO Xiaodeng, ZHAN Wei, LIU Tao, WANG Yiying. Association between Cumulative Lipid Accumulation Index and Hypertension: a Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(18): 2205-2211. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||